FHTX earnings: real EPS beat/miss history, analyst consensus Buy, P/E -4.45. Updated 2026-07-23.
Foghorn Therapeutics (FHTX) Research Hub
Foghorn Therapeutics (FHTX) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-09-11, shares last closed at 4.42 USD (-5.35%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -4.45, market cap 0.30B. This hub links to the full technical, earnings and options research available for FHTX.
Last updated 2026-09-11 · Source: FMP end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 4.42 USD (-5.35%) |
| 52-week range | 3.98 USD – 7.35 USD |
| Trend regime | Range |
| 14-day RSI | 29.1 (Oversold) |
| Trailing P/E | -4.45 |
| Market cap | 0.30B |
| Dividend yield | 0.00% |
Available research for FHTX
Covered Call on FHTX: how it works, illustrative setup around the real 4.42 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on FHTX: how it works, illustrative setup around the real 4.42 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on FHTX: how it works, illustrative setup around the real 4.42 USD price, max profit/loss, breakeven and when to use it. Educational.
FHTX technical analysis: range, last 4.42 USD, RSI 29.1, 52w range 3.98 USD–7.35 USD, real support/resistance. Updated 2026-09-11.
Frequently asked questions
What sector is FHTX in?
Foghorn Therapeutics (FHTX) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is FHTX in an uptrend or downtrend?
As of 2026-09-11, FHTX is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is FHTX's trailing P/E ratio?
FHTX's trailing P/E is -4.45, with a market cap of 0.30B. See the earnings research page for full valuation detail.